|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||0.79|
|PE ratio (TTM)||28.43|
|Earnings date||01 May 2023 - 05 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
MELVILLE, N.Y., March 28, 2023--Henry Schein, Inc. (Nasdaq: HSIC) announced its presence at the 2023 ADSO Annual Summit, including thought-leadership presentations on the future of dentistry and intrapreneurship as well as activities to support communities in need.
Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.